A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine a clinically safe and effective dose of intravitreally injected ISIS 2922 and to
compare the safety and efficacy of immediate versus delayed treatment in AIDS patients with
previously untreated, peripheral cytomegalovirus ( CMV ) retinitis.